ID: ALA5094291

Max Phase: Preclinical

Molecular Formula: C10H15NOS

Molecular Weight: 197.30

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CNC[C@]1(C)OCCc2ccsc21

Standard InChI:  InChI=1S/C10H15NOS/c1-10(7-11-2)9-8(3-5-12-10)4-6-13-9/h4,6,11H,3,5,7H2,1-2H3/t10-/m0/s1

Standard InChI Key:  KJOMHRUJAVDLSX-JTQLQIEISA-N

Associated Targets(Human)

Trace amine-associated receptor 1 1397 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 197.30Molecular Weight (Monoisotopic): 197.0874AlogP: 1.76#Rotatable Bonds: 2
Polar Surface Area: 21.26Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.40CX LogP: 1.78CX LogD: -0.20
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.78Np Likeness Score: 0.00

References

1. Heffernan MLR, Herman LW, Brown S, Jones PG, Shao L, Hewitt MC, Campbell JE, Dedic N, Hopkins SC, Koblan KS, Xie L..  (2022)  Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia.,  13  (1.0): [PMID:35047111] [10.1021/acsmedchemlett.1c00527]

Source